Shore Capital is pleased to be appointed as Joint Corporate Broker to Creo Medical Group plc (the ‘Company’, ‘Creo’)

Creo is an established UK based medical technology company specialising in advanced energy based electrosurgical systems designed to improve clinical outcomes in therapeutic endoscopy and minimally invasive procedures.

Creo’s core platform, CROMA, represents the Company’s flagship innovation. It combines adaptive bipolar radiofrequency with super high frequency microwave energy to power a suite of single and multi modality electrosurgical devices, enabling clinicians to undertake precise tissue cutting, coagulation, ablation, and related therapeutic interventions.

We look forward to working with the Creo team.